The CHIPTS Combination Prevention (CP) Core promotes development and evaluation of interventions that integrate evidence-based behavioral, biomedical, technological and structural components to reduce HIV incidence and to optimize each step of the HIV care and prevention continua. In response to strategic planning and anticipation of the medicalization of HIV prevention, the CP Core focuses its resources on guiding efforts that address persistent gaps in access and adherence to care and prevention in key populations, including men who have sex with men of color, African American women, transgender individuals, youth, homeless, and incarcerated individuals. Within these key populations, we further target those with comorbidities of substance use and mental health disorders and other factors that interfere with access and adherence to antiretroviral therapy (ART). While efforts to produce measurable outcomes (e.g., viral suppression, reduction in incidence) to HIV prevention have shown remarkable success using ART, the research was conducted on populations compliant with medications. Yet the disorganizing effects in key populations of comorbid substance use and mental health disorders contribute to ?leaks? in the HIV prevention and care continua. Its three specific aims are: (1) SCIENCE: To lead the science agenda on combining behavioral, biomedical, technological and structural interventions to optimize HIV care and HIV prevention outcomes, with a focus on those with mental health and/or substance use disorders, domestically and globally; to lead in scientific research networks (e.g., HPTN, ACTG); (2) NETWORKING: To convene activities that present best practices for dissemination and scale-up of behavioral, biomedical, technological, and structural interventions; to promote science development by engaging investigators and community stakeholders; (3) CAPACITY BUILDING: To build capacity within affected communities, key stakeholders, and service organizations through community education and workforce training; to mentor emerging scientists and faculty on combination prevention approaches; to facilitate linkages between community members interested in HIV therapeutic or prevention research with ongoing research opportunities. This coordinated agenda of science, networking and capacity building will generate vanguard information and expertise that will guide efforts towards HIV eradication in both the general population and in key populations. The CP Core team is led by Director Cathy Reback, PhD, Co-Director Raphael Landovitz MD, MSc, and Associate Director Danielle Harris, MPH. Core services include: advise on research on combination HIV prevention; provide guidance on study of substance use and mental health in the context of HIV prevention; provide peer review; translate domestic HIV prevention strategies for use in foreign settings and back; advise and train cultural competence, especially in key populations with comorbid conditions; conduct workforce training; mentor emerging academicians.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
5P30MH058107-24
Application #
9864093
Study Section
Special Emphasis Panel (ZMH1)
Project Start
Project End
Budget Start
2020-02-01
Budget End
2021-01-31
Support Year
24
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Lan, Chiao-Wen; Lin, Chunqing; Thanh, Duong Cong et al. (2018) Drug-related stigma and access to care among people who inject drugs in Vietnam. Drug Alcohol Rev 37:333-339
Montgomery, Tiffany M; Mays, Vickie M; Heilemann, MarySue V et al. (2018) Acceptability and Feasibility of a Sexual Health Intervention for Young Adult Black Women. J Obstet Gynecol Neonatal Nurs 47:862-873
Javanbakht, Marjan; Westmoreland, Drew; Gorbach, Pamina (2018) Factors Associated With Pharyngeal Gonorrhea in Young People: Implications for Prevention. Sex Transm Dis 45:588-593
Joseph Davey, Dvora; Farley, Elise; Towriss, Catriona et al. (2018) Risk perception and sex behaviour in pregnancy and breastfeeding in high HIV prevalence settings: Programmatic implications for PrEP delivery. PLoS One 13:e0197143
Li, Li; Hien, Nguyen Tran; Liang, Li-Jung et al. (2018) Efficacy of Communication Training of Community Health Workers on Service Delivery to People Who Inject Drugs in Vietnam: A Clustered Randomized Trial. Am J Public Health 108:791-798
Reback, Cathy J; RĂ¼nger, Dennis; Fletcher, Jesse B et al. (2018) Ecological momentary assessments for self-monitoring and counseling to optimize methamphetamine treatment and sexual risk reduction outcomes among gay and bisexual men. J Subst Abuse Treat 92:17-26
Fehrenbacher, Anne E; Chowdhury, Debasish; Jana, Smarajit et al. (2018) Consistent Condom Use by Married and Cohabiting Female Sex Workers in India: Investigating Relational Norms with Commercial Versus Intimate Partners. AIDS Behav :
Cunningham, William E; Weiss, Robert E; Nakazono, Terry et al. (2018) Effectiveness of a Peer Navigation Intervention to Sustain Viral Suppression Among HIV-Positive Men and Transgender Women Released From Jail: The LINK LA Randomized Clinical Trial. JAMA Intern Med 178:542-553
Fulcher, Jennifer A; Du, Yushen; Zhang, Tian-Hao et al. (2018) Emergence of Integrase Resistance Mutations During Initial Therapy Containing Dolutegravir. Clin Infect Dis 67:791-794
Lin, Chunqing; Lan, Chiao-Wen; Li, Li et al. (2018) Service providers' adherence to methadone maintenance treatment protocol in China. Int J Drug Policy 56:1-5

Showing the most recent 10 out of 715 publications